Silk Road Medical (SILK)
(Delayed Data from NSDQ)
$27.02 USD
+0.01 (0.04%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $27.04 +0.02 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Silk Road Medical (SILK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$22.30 | $27.50 | $8.00 | -17.44% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Silk Road Medical comes to $22.30. The forecasts range from a low of $8.00 to a high of $27.50. The average price target represents a decline of 17.44% from the last closing price of $27.01.
Analyst Price Targets (5 )
Broker Rating
Silk Road Medical currently has an average brokerage recommendation (ABR) of 3.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 2.63 a month ago based on eight recommendations.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/SILK.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 2 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 5 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 0 | 1 | 1 |
ABR | 3.38 | 3.38 | 2.63 | 2.50 | 2.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/16/2024 | Not Identified | Not Identified | Strong Buy | Hold |
7/11/2024 | Argus Research Corp. | Steve Silver | Strong Buy | Strong Sell |
6/18/2024 | Lake Street Capital Markets | Frank Takkinen | Strong Buy | Hold |
5/1/2024 | C.L. King & Associates | Kristen M Stewart | Hold | Hold |
5/1/2024 | Piper Sandler | Adam C Maeder | Hold | Hold |
10/24/2023 | Not Identified | Not Identified | Strong Sell | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.38 |
ABR (Last week) | 3.38 |
# of Recs in ABR | 8 |
Average Target Price | $22.30 |
LT Growth Rate | 1.60% |
Industry | Medical - Instruments |
Industry Rank by ABR | 96 of 252 |
Current Quarter EPS Est: | -0.38 |